Angiogenic factors for the prediction of preeclampsia in high-risk women
- 30 September 2007
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 197 (3), 244.e1-244.e8
- https://doi.org/10.1016/j.ajog.2007.06.030
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Sequential Changes in Antiangiogenic Factors in Early Pregnancy and Risk of Developing PreeclampsiaHypertension, 2007
- Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2007
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaNew England Journal of Medicine, 2006
- Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studiesBMJ, 2005
- Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia developAmerican Journal of Obstetrics and Gynecology, 2004
- Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2004
- Circulating Angiogenic Factors and the Risk of PreeclampsiaNew England Journal of Medicine, 2004
- Antenatal Corticosteroid Therapy for Fetal MaturationInternational Journal of Gynecology & Obstetrics, 2002
- Practice bulletin #33: diagnosis and management of preeclampsia and eclampsiaObstetrics & Gynecology, 2002
- What Are the Fetal Growth Patterns of Singletons, Twins, and Triplets in the United States?Clinical Obstetrics and Gynecology, 1998